AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

12,404.00p
   
  • Change Today:
      44.00p
  • 52 Week High: 12,450.00
  • 52 Week Low: 9,501.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.24m
  • Volume: 1,045,817
  • Market Cap: £192,291m
  • RiskGrade: 123

Income Statement - Normalised

  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Continuing Operations          
Revenue 45,811.00 44,351.00 37,417.00 26,617.00 24,384.00
           
EBITDA 13,580.00 9,237.00 6,536.00 8,549.00 1,548.00
Depreciation & Amortisation (5,387.00) (5,480.00) (5,480.00) (2,896.00) n/a
           
Operating Profit/(Loss) 8,193.00 3,757.00 1,056.00 5,653.00 1,548.00
Interest Payable (1,626.00) (1,346.00) (1,300.00) (1,306.00) n/a
Interest Receivable/Investment Income 344.00 95.00 43.00 87.00 n/a
           
Group Profit after Interest 6,911.00 2,506.00 (201.00) 4,434.00 1,548.00
Share of Assoc Cos/JV Profits (12.00) (5.00) (64.00) (27.00) n/a
           
Profit Before Tax 6,899.00 2,501.00 (265.00) 4,407.00 1,548.00
Tax (938.00) 792.00 380.00 (822.00) (321.00)
           
Profit After Tax 5,961.00 3,293.00 115.00 3,585.00 1,227.00
           
Discontinued Operations          
Profit After Tax n/a n/a n/a n/a n/a
           
PROFIT FOR PERIOD 5,961.00 3,293.00 115.00 3,585.00 1,227.00
           
Attributable to:          
Equity Holders of Parent Company 5,955.00 3,288.00 112.00 3,637.00 1,335.00
Minority Interests (6.00) (5.00) (3.00) 52.00 108.00
           
Equity Dividends cn/a cn/a cn/a cn/a cn/a
Retained Profit/(Loss) for the Financial Year c5,955.00 c3,288.00 c112.00 c3,637.00 c1,335.00


Per Share Record - Normalised 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Continuing EPS          
Earnings per Share - Basic 384.44¢ 212.40¢ 7.90¢ 277.21¢ 102.61¢
Earnings per Share - Diluted 381.24¢ 210.77¢ 7.85¢ 277.00¢ 102.61¢
Earnings per Share - Adjusted 384.00¢ 212.00¢ 8.00¢ 244.00¢ 103.00¢
Continuing and Discontinued EPS          
Earnings per Share - Basic 384.44¢ 212.40¢ 0.080¢ 277.21¢ 102.61¢
Earnings per Share - Diluted 381.24¢ 210.77¢ 0.079¢ 277.00¢ 102.61¢
Earnings per Share - Adjusted 384.00¢ 212.00¢ 8.00¢ 244.00¢ 103.00¢
           
Dividend per Share 290.00¢ 290.00¢ 287.00¢ 280.00¢ 280.00¢


Key Financals 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Shares in Issue (millions)          
Shares in Issue - Year End 1,550.16 1,549.80 1,549.40 1,312.67 1,312.14
Weighted Average 1,549.00 1,548.00 1,418.00 1,312.00 1,301.00
Diluted 1,562.00 1,560.00 1,427.00 1,313.00 1,301.00
           
Performance Ratios          
Continuing Operations          
Operating Margin 17.88% 8.47% 2.82% 21.24% 6.35%
Return on Capital Employed 60.06% 34.10% 0.07% 83.62% 42.38%
Continuing Operations & Discontinued Operations          
Return on Equity 13.81% 8.04% n/a 19.02% 8.11%
           
Financial Status          
Continuing Operations          
Interest Cover - Continuing 5.24 2.86 0.80 4.37 n/a
Revenue per Share 2,957.46¢ 2,865.05¢ 26.64¢ 2,028.73¢ 1,874.25¢
Pre-Tax Profit Per Share - Continuing 445.38¢ 161.56¢ (0.19¢) 335.90¢ 118.98¢
           
Market Data          
Continuing Operations          
Earnings Per Share Growth - Basic 81% 2,589% -97% 170% -40%
Earnings Per Share Growth - Diluted 81% 2,585% -97% 170% -40%
PE Ratio - Company Adjusted 35.1 67.2 1,397.1 33.6 94.3
PEG - Company Adjusted 0.4 0.0 n/a 0.2 n/a
Dividend Cover 1.33 0.73 0.03 0.99 0.37
Continuing Operations & Discontinued Operations          
Earnings per Share - Company Adjusted 81% 266,312% -100% 170% 21%
Earnings per Share - Diluted 81% 265,941% -100% 170% 21%
PE Ratio - Company Adjusted 35.1 67.2 138,406.6 33.6 94.3
PEG - Company Adjusted 0.4 0.0 n/a 0.2 4.5
Dividend Cover 1.33 0.73 n/a 0.99 0.37
           
Market Capitalisation $ (Millions) 164,317.24 173,856.57 134,456.99 96,139.85 99,814.33
Dividend per Share 290.00¢ 290.00¢ 287.00¢ 280.00¢ 280.00¢
Dividend Yield 2.2% 2.0% 2.6% 3.0% 2.9%
Dividend per Share Growth n/a 1.05% 2.50% n/a n/a

Key

* GAAP

a. Includes discontinued activities

b. Includes preference dividends

c. Not disclosed under IFRS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page